Contents

Current Neuropharmacology, Volume 14 - Number 3

Meet Our Editorial Board Member:

, 14(3): 211

Karim Alkadhi


DOI: 10.2174/1570159X1403160303151230




Editorial (Thematic Selection: Critical Analyses of Mechanism-Based Therapies Against Parkinson’s Disease: Concepts and Perspectives)

, 14(3): 212 - 213

Marco Bisaglia


DOI: 10.2174/1570159X1403160303151355




LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson’s Disease, Where Do We Stand?

, 14(3): 214 - 225

Jean-Marc Taymans and Elisa Greggio


DOI: 10.2174/1570159X13666151030102847





Modulating the Amyloidogenesis of α-Synuclein

, 14(3): 226 - 237

Kalkena Sivanesam and Niels H. Andersen


DOI: 10.2174/1570159X13666151030103153





Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinson´s Disease

, 14(3): 238 - 249

Pilar Rivero-Ríos, Jesús Madero-Pérez,, Belén Fernández and Sabine Hilfiker


DOI: 10.2174/1570159X13666151030103027





Counteracting PINK/Parkin Deficiency in the Activation of Mitophagy: A Potential Therapeutic Intervention for Parkinson’s Disease

, 14(3): 250 - 259

Alice Nardin, Emilie Schrepfer and Elena Ziviani


DOI: 10.2174/1570159X13666151030104414





Anti-Oxidants in Parkinson’s Disease Therapy: A Critical Point of View

, 14(3): 260 - 271

Roberta Filograna, Mariano Beltramini, Luigi Bubacco and Marco Bisaglia


DOI: 10.2174/1570159X13666151030102718





Methylphenidate on Cognitive Improvement in Patients with Traumatic Brain Injury: A Meta-Analysis

, 14(3): 272 - 281

Chi-Hsien Huang, Chia-Chen Huang, Cheuk-Kwan Sun, Gong-Hong Lin and Wen-Hsuan Hou


DOI: 10.2174/1570159X13666150514233033





Selenium in the Therapy of Neurological Diseases. Where is it Going?

, 14(3): 282 - 299

Agnieszka Dominiak, Anna Wilkaniec, Piotr Wroczyński and Agata Adamczyk


DOI: 10.2174/1570159X14666151223100011





Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science